Cost-effectiveness analysis of guidelines for antihypertensive care in Finland (Q33303769)

25 July 2017

Cost-effectiveness analysis of guidelines for antihypertensive care in Finland (English)

1 reference

cost-effectiveness analysis

25 July 2017

0 references

1 reference

Katriina Kukkonen-Harjula

inferred from title

author

6

object named as

Katriina Kukkonen-Harjula

1 reference

25 July 2017

9

Harri Sintonen

1 reference

25 July 2017

2

Antti Jula

1 reference

25 July 2017

Neill Booth

1

1 reference

25 July 2017

Pasi Aronen

3

1 reference

25 July 2017

Minna Kaila

4

1 reference

25 July 2017

Timo Klaukka

5

1 reference

25 July 2017

Antti Reunanen

7

1 reference

25 July 2017

Pekka Rissanen

8

1 reference

25 July 2017

Marjukka Mäkelä

10

1 reference

25 July 2017

24 October 2007

1 reference

BMC Health Services Research

25 July 2017

1 reference

25 July 2017

7

1 reference

25 July 2017

172

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6963-7-172

25 July 2017

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Clinical practice guidelines and organizational adaptation: a framework for analyzing economic effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Interventions used to improve control of blood pressure in patients with hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost-effectiveness of implementing new guidelines for treatment of hypertension in general practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Modelling in the economic evaluation of health care: selecting the appropriate approach

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in eastern Finland

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

The 15D instrument of health-related quality of life: properties and applications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost effectiveness of combination HIV therapy: 3 years later

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Evaluation of the relative cost-effectiveness of treatments for infertility in the UK.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Costs of coronary heart disease and stroke: the case of Sweden.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diuretics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

The cost-effectiveness of the switch towards more expensive antihypertensive drugs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Measurement of health outcome and associated costs in cardiovascular disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost-effectiveness of antihypertensive treatment. General considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

The CE plane: a graphic representation of cost-effectiveness.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

An updated coronary risk profile. A statement for health professionals.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

Direct medical costs of coronary artery disease in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

Towards the equitably efficient and transparently decidable use of public funds in the deep blue millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

The Cost Effectiveness of Hypertension Treatment in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

Financial and health costs of uncontrolled blood pressure in the United Kingdom.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2174470

Comparisons of Hypertension-Related Costs from Multinational Clinical Studies

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6963-7-172

Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?

21 January 2018

1 reference

12 December 2020

Use and misuse of the term "cost effective" in medicine

1 reference

12 December 2020

Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension

1 reference

12 December 2020

Long-term nopharmacological treatment for mild to moderate hypertension

1 reference

12 December 2020

The cost-effectiveness of treating hypertension in elderly people--an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)

1 reference

12 December 2020

Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension

1 reference

12 December 2020

Moderately elevated blood pressure. A report from SBU, the Swedish Council on Technology Assessment in Health Care

1 reference

12 December 2020

Long-term cost and life-expectancy consequences of hypertension

1 reference

12 December 2020

Cost-effectiveness of felodipine-metoprolol (Logimax) and enalapril in the treatment of hypertension

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

12 December 2020

Cost-effectiveness analysis of lead poisoning screening strategies following the 1997 guidelines of the Centers for Disease Control and Prevention

1 reference

12 December 2020

Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring

1 reference

12 December 2020

The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis

1 reference

12 December 2020

Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?

1 reference

12 December 2020

[Treatment of hypertension]

1 reference

12 December 2020

Cardiovascular disease costs associated with uncontrolled hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6963-7-172

1 reference

25 July 2017

1 reference

25 July 2017

1 reference